ArticleEuropean child & adolescent psychiatry2026
The development and course of youth psychopathology: a longitudinal study of prevalence and continuity from early childhood through late adolescence.
Article in European child & adolescent psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Youth mental disorders are prevalent and show homotypic and heterotypic continuity. We followed a community sample of 609 families with 3-year-old children living within 20 contiguous miles of Stony Brook, NY, with at least one biological parent; primary caregivers were required to speak English, and children with significant medical or developmental disorders were excluded. Participants were assessed at three-year intervals from ages 3-18, tracking the prevalence and continuity of five common mental disorders (depression, anxiety, attention-deficit/hyperactivity disorder, disruptive behavior, and substance use disorders) via semi-structured diagnostic interviews. By age 18, estimated cumulative prevalence rates were: depression (34.7%), anxiety (55.9%), disruptive behavior disorders (DBD; 19.4%), attention deficit hyperactivity disorder (ADHD; 22.6%), and substance use disorders (SUD; 11.9%). Depression prevalence rose with age; anxiety remained consistently high; DBD declined after age 6; ADHD peaked at age 12; and SUD sharply increased at age 18. The cumulative prevalence of any mental disorder by age 18 was 71.8%. We found substantial homotypic and heterotypic continuity. The latter was greater within than between the internalizing and externalizing domains. Early psychopathology (< age 6) significantly increased later disorder risk. These data highlight the substantial burden and developmental course of common youth mental disorders from preschool through late adolescence.
Indexed as
Identifiers
42334576What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.